PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,050,472 | -34.9% | 125,805 | +3.7% | 0.01% | -30.0% |
| Q2 2023 | $1,613,716 | +16.6% | 121,332 | +1.5% | 0.01% | +11.1% |
| Q1 2023 | $1,384,343 | +58.4% | 119,546 | +11.9% | 0.01% | +50.0% |
| Q4 2022 | $874,058 | +40.3% | 106,853 | -0.4% | 0.01% | +20.0% |
| Q3 2022 | $623,000 | +33.4% | 107,241 | +1.4% | 0.01% | +66.7% |
| Q2 2022 | $467,000 | -46.9% | 105,727 | +9.5% | 0.00% | -40.0% |
| Q1 2022 | $879,000 | -58.4% | 96,553 | -6.6% | 0.01% | -54.5% |
| Q4 2021 | $2,115,000 | -22.2% | 103,349 | -2.9% | 0.01% | -21.4% |
| Q3 2021 | $2,720,000 | -28.6% | 106,441 | -2.3% | 0.01% | +7.7% |
| Q2 2021 | $3,811,000 | +7.6% | 108,970 | +2.5% | 0.01% | +8.3% |
| Q1 2021 | $3,541,000 | +32.8% | 106,294 | +3.4% | 0.01% | +20.0% |
| Q4 2020 | $2,666,000 | +170.7% | 102,786 | +3.0% | 0.01% | +100.0% |
| Q3 2020 | $985,000 | +220.8% | 99,772 | +12.1% | 0.01% | +400.0% |
| Q2 2020 | $307,000 | +19.0% | 88,990 | +5.6% | 0.00% | 0.0% |
| Q1 2020 | $258,000 | -43.7% | 84,261 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $458,000 | -1.3% | 89,129 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $464,000 | -15.3% | 89,880 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $548,000 | -14.0% | 90,505 | +2.7% | 0.00% | 0.0% |
| Q1 2019 | $637,000 | -4.5% | 88,142 | -2.2% | 0.00% | -33.3% |
| Q4 2018 | $667,000 | +52.6% | 90,088 | +11.5% | 0.00% | +200.0% |
| Q3 2018 | $437,000 | +55.0% | 80,823 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $282,000 | +86.8% | 79,367 | +7.6% | 0.00% | 0.0% |
| Q1 2018 | $151,000 | -17.9% | 73,784 | +5.7% | 0.00% | 0.0% |
| Q4 2017 | $184,000 | -49.0% | 69,806 | +1.5% | 0.00% | 0.0% |
| Q3 2017 | $361,000 | +95.1% | 68,802 | +32.3% | 0.00% | 0.0% |
| Q2 2017 | $185,000 | -23.9% | 52,024 | +10.5% | 0.00% | 0.0% |
| Q1 2017 | $243,000 | +45.5% | 47,080 | +7.4% | 0.00% | 0.0% |
| Q4 2016 | $167,000 | -100.0% | 43,822 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $393,658,000 | +27.6% | 43,935 | +0.2% | 0.00% | +100.0% |
| Q2 2016 | $308,611,000 | +2.2% | 43,868 | +23.7% | 0.00% | 0.0% |
| Q1 2016 | $302,000,000 | -35.2% | 35,473 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $466,000,000 | +358361.5% | 35,473 | -0.2% | 0.00% | +100.0% |
| Q3 2015 | $130,000 | -99.9% | 35,535 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $204,440,000 | -3.2% | 35,493 | -1.9% | 0.00% | 0.0% |
| Q1 2015 | $211,198,000 | -25.5% | 36,164 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $283,526,000 | +53.6% | 36,164 | -3.8% | 0.00% | 0.0% |
| Q3 2014 | $184,591,000 | -20.6% | 37,595 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $232,504,000 | +33.6% | 37,622 | +15.7% | 0.00% | 0.0% |
| Q1 2014 | $173,993,000 | +4.8% | 32,522 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $166,005,000 | +0.4% | 31,741 | +6.2% | 0.00% | 0.0% |
| Q3 2013 | $165,264,000 | +156.8% | 29,885 | +17.0% | 0.00% | – |
| Q2 2013 | $64,346,000 | – | 25,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |